Senti Biosciences Holdings, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $36.3M | $96.7M | $0 |
| FY2022 | $53.5M | $180.8M | $57.6M |
| FY2023 | $52.6M | $119.5M | $35.9M |
| FY2024 | $47.1M | $97.8M | $48.3M |
| FY2025 | $45.6M | $51.2M | $16.4M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $36.3M | $96.7M | $0 |
| FY2022 | $53.5M | $180.8M | $57.6M |
| FY2023 | $52.6M | $119.5M | $35.9M |
| FY2024 | $47.1M | $97.8M | $48.3M |
| FY2025 | $45.6M | $51.2M | $16.4M |